doi: 10.1093/oxfordjournals.aje.a120717.
Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter
- PMID: 4378110
- DOI: 10.1093/oxfordjournals.aje.a120717
Item in Clipboard
Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter
Am J Epidemiol.
1967 Jul.
No abstract available
Similar articles
-
[Comparison of two schedules for administering trivalent oral poliovaccine].Zhonghua Yu Fang Yi Xue Za Zhi. 1985 Sep;19(5):275-7. Zhonghua Yu Fang Yi Xue Za Zhi. 1985. PMID: 3004841 Chinese. No abstract available.
-
[Determination of the virus content in oral trivalent candy poliovaccine using monoclonal antibodies to poliovirus].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1986 Feb;8(1):72-3. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1986. PMID: 3017590 Chinese. No abstract available.
-
Immunogenicity of oral poliovirus vaccine in Taiwan.J Formos Med Assoc. 1999 Dec;98(12):859-62. J Formos Med Assoc. 1999. PMID: 10634028
-
[Current concepts of the antigenic structure and attenuation mechanisms of the poliomyelitis virus].Vopr Virusol. 1988 Jul-Aug;33(4):389-92. Vopr Virusol. 1988. PMID: 2461613 Review. Russian. No abstract available.
-
Vaccines based on recombinant antigen strategies.Dev Biol (Basel). 2001;105:189-94. Dev Biol (Basel). 2001. PMID: 11763327 Review. No abstract available.
Cited by
-
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023. Front Public Health. 2024. PMID: 38259741 Free PMC article. Review.
-
Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria.J Infect Dis. 2024 Mar 14;229(3):805-812. doi: 10.1093/infdis/jiad222. J Infect Dis. 2024. PMID: 37357964 Free PMC article.
-
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.Lancet Infect Dis. 2023 Sep;23(9):1062-1071. doi: 10.1016/S1473-3099(23)00139-1. Epub 2023 May 10. Lancet Infect Dis. 2023. PMID: 37178706 Free PMC article. Clinical Trial.
-
Use of Oral Polio Vaccine and the Global Incidence of Mother-to-Child Human Immunodeficiency Virus Transmission.Front Public Health. 2022 Jun 9;10:878298. doi: 10.3389/fpubh.2022.878298. eCollection 2022. Front Public Health. 2022. PMID: 35812500 Free PMC article.
-
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A113-A121. doi: 10.1016/j.vaccine.2022.03.027. Epub 2022 Mar 29. Vaccine. 2023. PMID: 35365341 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
